The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Mitochondria in Huntington's disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
Chan, D. C. (2006) · Cell · doi:10.1016/j.cell.2006.06.010 · Cited by 1,987
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Newmeyer, D. D., & Ferguson-Miller, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00116-8 · Cited by 1,269
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Beal, M., Brouillet, E., Jenkins, B., Ferrante, R., Kowall, N., Miller, J., Storey, E., Srivastava, R., Rosen, B., & Hyman, B. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,027
Self-citationCui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 961
Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology
Gutekunst, C.-A., Li, S.-H., Yi, H., Mulroy, J. S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R. J., Hersch, S. M., & Li, X.-J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02522.1999 · Cited by 914
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 845
Regional and cellular gene expression changes in human Huntington's disease brain
Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Sengstag, T., Hughes, G., Elliston, L. A., Hartog, C., Goldstein, D. R., Thu, D., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl013 · Cited by 804
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Selective Sparing of a Class of Striatal Neurons in Huntington's Disease
Ferrante, R. J., Kowall, N. W., Beal, M. F., Richardson, E. P., Bird, E. D., & Martin, J. B. (1985) · Science · doi:10.1126/science.2931802 · Cited by 757
Molecular pathways to neurodegeneration
Bossy-Wetzel, E., Schwarzenbacher, R., & Lipton, S. A. (2004) · Nature Medicine · doi:10.1038/nm1067 · Cited by 740
Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 1×
“Loss of function in the gene coding one of the succinate dehydrogenase (SDHA) determines Leigh syndrome [57].”
BackgroundFerrante, R. J., Kubilus, J. K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi-Carter, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 693
Normal huntingtin function: an alternative approach to Huntington's disease
Cattaneo, E., Zuccato, C., & Tartari, M. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1806 · Cited by 657
Graham, R. K., Deng, Y., Slow, E. J., Haigh, B., Bissada, N., Lu, G., Pearson, J., Shehadeh, J., Bertram, L., Murphy, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2006.04.026 · Cited by 651
Gray, M., Shirasaki, D. I., Cepeda, C., Andre, V. M., Wilburn, B., Lu, X.-H., Tao, J., Yamazaki, I., Li, S.-H., Sun, Y. E., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0857-08.2008 · Cited by 613
Stipe, J., White, D., & Arsdale, E. V. (1979) · The American Journal of Nursing · doi:10.2307/3424618 · Cited by 602
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Wellington, C. L., Ellerby, L. M., Hackam, A. S., Margolis, R. L., Trifiro, M. A., Singaraja, R., McCutcheon, K., Salvesen, G. S., Propp, S. S., Bromm, M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9158 · Cited by 562
Sawa, A., Wiegand, G. W., Cooper, J., Margolis, R. L., Sharp, A. H., Lawler, J. F., Greenamyre, J. T., Snyder, S. H., & Ross, C. A. (1999) · Nature Medicine · doi:10.1038/13518 · Cited by 552
Huntingtin–protein interactions and the pathogenesis of Huntington's disease
Li, S.-H., & Li, X.-J. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.01.008 · Cited by 548
Transcriptional abnormalities in Huntington disease
Sugars, K. L., & Rubinsztein, D. C. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00074-x · Cited by 529
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Choo, Y. S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh162 · Cited by 515 · cited 4×
“One important point is that mutant Htt can interact with the outer mitochondrial membrane [50-53].”
BackgroundInfluentialNuclear control of respiratory gene expression in mammalian cells
Scarpulla, R. C. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20743 · Cited by 489
3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin
Ludolph, A. C., He, F., Spencer, P. S., Hammerstad, J., & Sabri, M. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032212 · Cited by 485
Brouillet, E., Hantraye, P., Ferrante, R. J., Dolan, R., Leroy-Willig, A., Kowall, N. W., & Beal, M. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7105 · Cited by 485
Self-citationp53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease
Bae, B.-I., Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., Hayward, S. D., Moran, T. H., Montell, C., Ross, C. A., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.005 · Cited by 485
Jenkins, B. G., Koroshetz, W. J., Beal, M. F., & Rosen, B. R. (1993) · Neurology · doi:10.1212/wnl.43.12.2689 · Cited by 478
N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking
Orr, A. L., Li, S., Wang, C.-E., Li, H., Wang, J., Rong, J., Xu, X., Mastroberardino, P. G., Greenamyre, J. T., & Li, X.-J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0106-08.2008 · Cited by 430
N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
FAN, M., & RAYMOND, L. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.003 · Cited by 413
Replicating Huntington's disease phenotype in experimental animals
Brouillet, E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00005-2 · Cited by 413
Self-citationOnset and rate of striatal atrophy in preclinical Huntington disease
Aylward, E. H., Sparks, B. F., Field, K. M., Yallapragada, V., Shpritz, B. D., Rosenblatt, A., Brandt, J., Gourley, L. M., Liang, K., Zhou, H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000132965.14653.d1 · Cited by 408
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Kim, Y. J., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K. B., Qin, Z.-H., Aronin, N., & DiFiglia, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221451398 · Cited by 398
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
Sorbi, S., Bird, E. D., & Blass, J. P. (1983) · Annals of Neurology · doi:10.1002/ana.410130116 · Cited by 396
Therapeutic Effects of Coenzyme Q10and Remacemide in Transgenic Mouse Models of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Dedeoglu, A., Ferrante, K. L., Jenkins, B. G., Hersch, S. M., & Beal, M. F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01592.2002 · Cited by 391
Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid
Brouillet, E., Jenkins, B. G., Hyman, B. T., Ferrante, R. J., Kowall, N. W., Srivastava, R., Roy, D. S., Rosen, B. R., & Beal, M. F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05859.x · Cited by 367
Brouillet, E., Jacquard, C., Bizat, N., & Blum, D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03515.x · Cited by 364
Self-citationScarpulla, R. C. (2002) · Gene · doi:10.1016/s0378-1119(01)00809-5 · Cited by 345
Calpain Activation in Huntington's Disease
Gafni, J., & Ellerby, L. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04842.2002 · Cited by 331
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG
Hersch, S. M., Gevorkian, S., Marder, K., Moskowitz, C., Feigin, A., Cox, M., Como, P., Zimmerman, C., Lin, M., Zhang, L., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000194318.74946.b6 · Cited by 313
The corticostriatal pathway in Huntington's disease
CEPEDA, C., WU, N., ANDRE, V, CUMMINGS, D., & LEVINE, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.001 · Cited by 310
Oxidative Damage in Huntington's Disease Pathogenesis
Browne, S. E., & Beal, M. F. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2061 · Cited by 310
Proteomic and oxidative stress analysis in human brain samples of Huntington disease
Sorolla, M. A., Reverter-Branchat, G., Tamarit, J., Ferrer, I., Ros, J., & Cabiscol, E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.014 · Cited by 301
Calcium ions in neuronal degeneration
Wojda, U., Salinska, E., & Kuznicki, J. (2008) · IUBMB Life · doi:10.1002/iub.91 · Cited by 301
Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons
Chang, D. T. W., Rintoul, G. L., Pandipati, S., & Reynolds, I. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.007 · Cited by 299
Sun, Y., Savanenin, A., Reddy, P. H., & Liu, Y. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103501200 · Cited by 297
Ferrante, R. J., Kowall, N. W., Beal, M. F., Martin, J. B., Bird, E. D., & Richardson, E. P. (1987) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198701000-00002 · Cited by 294
Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., Jenkins, B. G., Ferrante, K. L., Thomas, M., Friedlich, A., Browne, S. E., Schilling, G., Borchelt, D. R., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0406 · Cited by 293
Laforet, G. A., Sapp, E., Chase, K., McIntyre, C., Boyce, F. M., Campbell, M., Cadigan, B. A., Warzecki, L., Tagle, D. A., Reddy, P. H., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09112.2001 · Cited by 290
Rockabrand, E., Slepko, N., Pantalone, A., Nukala, V. N., Kazantsev, A., Marsh, J. L., Sullivan, P. G., Steffan, J. S., Sensi, S. L., & Thompson, L. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl440 · Cited by 286
Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity
Gafni, J., Hermel, E., Young, J. E., Wellington, C. L., Hayden, M. R., & Ellerby, L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401267200 · Cited by 281
Mutant huntingtin and mitochondrial dysfunction
Bossy-Wetzel, E., Petrilli, A., & Knott, A. B. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.004 · Cited by 268
Transcriptional signatures in Huntington's disease
Cha, J.-H. J. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.03.004 · Cited by 268
Regional Mitochondrial Respiratory Activity in Huntington's Disease Brain
Brennan, W. A., Bird, E. D., & Aprille, J. R. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07192.x · Cited by 264
Succinate dehydrogenase and human diseases: new insights into a well-known enzyme
Rustin, P., Munnich, A., & Rötig, A. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200793 · Cited by 257
Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease
Ferrante, R. J., Flint Beal, M., Kowall, N. W., Richardson, E. P., & Martin, J. B. (1987) · Brain Research · doi:10.1016/0006-8993(87)90694-9 · Cited by 257
Deranged neuronal calcium signaling and Huntington disease
Bezprozvanny, I., & Hayden, M. R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.035 · Cited by 255
Lodi, R., Schapira, A. H. V., Manners, D., Styles, P., Wood, N. W., Taylor, D. J., & Warner, T. T. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<72::aid-ana11>3.0.co;2-i · Cited by 254
Benchoua, A., Trioulier, Y., Zala, D., Gaillard, M.-C., Lefort, N., Dufour, N., Saudou, F., Elalouf, J.-M., Hirsch, E., Hantraye, P., et al. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0607 · Cited by 248
Self-citationTopography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.
Kassubek, J., Juengling, F. D., Kioschies, T. A., Henkel, K., Karitzky, J., Kramer, B., Ecker, D., Andrich, J., Carsten Saft, C., Kraus, P., et al. (2004) · PubMed · Cited by 246
Bioenergetics and glutamate excitotoxicity
Greene, J. G., & Greenamyre, J. T. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00006-8 · Cited by 245
Ferrante, R. J., Kowall, N. W., Cipolloni, P. B., Storey, E., & Beal, M. F. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1006 · Cited by 244
1 H NMR spectroscopy studies of Huntington's disease: Correlations with CAG repeat numbers
Jenkins, B. G., Rosas, H. D., Chen, Y.-C. I., Makabe, T., Myers, R., MacDonald, M., Rosen, B. R., Beal, M. F., & Koroshetz, W. J. (1998) · Neurology · doi:10.1212/wnl.50.5.1357 · Cited by 238
Experimental therapeutics in transgenic mouse models of Huntington's disease
Beal, M. F., & Ferrante, R. J. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1386 · Cited by 222
Huntington’s disease: from huntingtin function and dysfunction to therapeutic strategies
Borrell-Pagès, M., Zala, D., Humbert, S., & Saudou, F. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6242-0 · Cited by 222
Sustained effects of nonallele‐specific Huntingtin silencing
Drouet, V., Perrin, V., Hassig, R., Dufour, N., Auregan, G., Alves, S., Bonvento, G., Brouillet, E., Luthi‐Carter, R., Hantraye, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21569 · Cited by 216
Self-citationNeuronal Life-and-Death Signaling, Apoptosis, and Neurodegenerative Disorders
Mattson, M. P. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1997 · Cited by 214
Strand, A. D., Baquet, Z. C., Aragaki, A. K., Holmans, P., Yang, L., Cleren, C., Beal, M. F., Jones, L., Kooperberg, C., Olson, J. M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2461-07.2007 · Cited by 212
Parfait, B., Chretien, D., Rötig, A., Marsac, C., Munnich, A., & Rustin, P. (2000) · Human Genetics · doi:10.1007/s004390051033 · Cited by 211
Petersen, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1243 · Cited by 210
Dopaminergic Signaling and Striatal Neurodegeneration in Huntington's Disease
Tang, T.-S., Chen, X., Liu, J., & Bezprozvanny, I. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1396-07.2007 · Cited by 209
Guidetti, P., Charles, V., Chen, E.-Y., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R., & Tagle, D. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7626 · Cited by 198
Mutant Huntingtin Enhances Excitotoxic Cell Death
Zeron, M. M., Chen, N., Moshaver, A., Ting-Chun Lee, A., Wellington, C. L., Hayden, M. R., & Raymond, L. A. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0909 · Cited by 197
Neuronal cell death in Huntington’s disease: a potential role for dopamine
Jakel, R. J., & Maragos, W. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01568-x · Cited by 197
Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
Lim, D., Fedrizzi, L., Tartari, M., Zuccato, C., Cattaneo, E., Brini, M., & Carafoli, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704704200 · Cited by 193
Gray, N. K., Pantopoulos, K., Dandekar, T., Ackrell, B. A., & Hentze, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4925 · Cited by 187
Proteomic Analysis of Protein Expression and Oxidative Modification in R6/2 Transgenic Mice
Perluigi, M., Poon, H. F., Maragos, W., Pierce, W. M., Klein, J. B., Calabrese, V., Cini, C., De Marco, C., & Butterfield, D. A. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500090-mcp200 · Cited by 186
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect
Levine, M. S., Cepeda, C., Hickey, M. A., Fleming, S. M., & Chesselet, M.-F. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.008 · Cited by 183
Clinical and neuropathologic assessment of severity in Huntington's disease
Myers, R. H., Vonsattel, J. P., Stevens, T. J., Cupples, L. A., Richardson, E. P., Martin, J. B., & Bird, E. D. (1988) · Neurology · doi:10.1212/wnl.38.3.341 · Cited by 178
Hypothalamic–endocrine aspects in Huntington's disease
Petersén, Å., & Björkqvist, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04985.x · Cited by 177
Mitochondria and Huntington's Disease Pathogenesis: Insight from Genetic and Chemical Models
Browne, S. E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.018 · Cited by 176
Dedeoglu, A., Kubilus, J. K., Yang, L., Ferrante, K. L., Hersch, S. M., Beal, M. F., & Ferrante, A. R. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01706.x · Cited by 169
Evidence of Oxidant Damage in Huntington's Disease: Translational Strategies Using Antioxidants
Stack, E. C., Matson, W. R., & Ferrante, R. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.008 · Cited by 166
Ryu, H., Lee, J., Impey, S., Ratan, R. R., & Ferrante, R. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502878102 · Cited by 165
Wild-Type Huntingtin Plays a Role in Brain Development and Neuronal Survival
Reiner, A., Dragatsis, I., Zeitlin, S., & Goldowitz, D. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:3:259 · Cited by 165
Bizat, N., Hermel, J.-M., Boyer, F., Jacquard, C., Créminon, C., Ouary, S., Escartin, C., Hantraye, P., Krajewski, S., & Brouillet, E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05020.2003 · Cited by 164
Self-citationSelective Neuronal Degeneration in Huntington's Disease
(2006) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)75002-5 · Cited by 163
Calabresi, P., Gubellini, P., Picconi, B., Centonze, D., Pisani, A., Bonsi, P., Greengard, P., Hipskind, R. A., Borrelli, E., & Bernardi, G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05110.2001 · Cited by 163
Knock-in mouse models of Huntington’s disease
Menalled, L. (2005) · NeuroRx · doi:10.1602/neurorx.2.3.465 · Cited by 159
Charvin, D., Vanhoutte, P., Pagès, C., Borelli, E., & Caboche, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502698102 · Cited by 159
Solans, A., Zambrano, A., Rodríguez, M., & Barrientos, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl248 · Cited by 158
Rodent genetic models of Huntington disease
Heng, M. Y., Detloff, P. J., & Albin, R. L. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.005 · Cited by 152
Butterworth, J., Yates, C. M., & Reynolds, G. P. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90112-1 · Cited by 150
Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics
Blum, D. L., Hourez, R., Galas, M., Popoli, P., & Schiffmann, S. N. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00411-3 · Cited by 149
Mitochondrial function and parental sex effect in Huntington's disease
Mann, V. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)92242-a · Cited by 147
Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells
Milakovic, T., Quintanilla, R. A., & Johnson, G. V. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603845200 · Cited by 147
Mitochondrial Complex III Deficiency Associated with a Homozygous Mutation in UQCRQ
Barel, O., Shorer, Z., Flusser, H., Ofir, R., Narkis, G., Finer, G., Shalev, H., Nasasra, A. E., Saada, A., & Birk, O. S. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.03.020 · Cited by 147
Oliveira, J. M. A., Chen, S., Almeida, S., Riley, R. R., Gonçalves, J., Oliveira, C. R., Hayden, M. R., Nicholls, D. G., Ellerby, L., & Rego, A. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3004-06.2006 · Cited by 147
Progress in understanding structure-function relationships in respiratory chain complex II.
Ackrell, B. A. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01749-4 · Cited by 144
Oliveira, J. M. A., Jekabsons, M. B., Chen, S., Lin, A., Rego, A. C., Gonçalves, J., Ellerby, L., & Nicholls, D. G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04361.x · Cited by 136
PGC-1α, a New Therapeutic Target in Huntington's Disease?
McGill, J. K., & Beal, M. F. (2006) · Cell · doi:10.1016/j.cell.2006.10.023 · Cited by 131
Heng, M. Y., Detloff, P. J., Wang, P. L., Tsien, J. Z., & Albin, R. L. (2008) · Nature Precedings · doi:10.1523/jneurosci.5599-08.2009 · Cited by 131
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
Smith, K. M., Matson, S., Matson, W. R., Cormier, K., Del Signore, S. J., Hagerty, S. W., Stack, E. C., Ryu, H., & Ferrante, R. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.004 · Cited by 127
Popoli, P., Blum, D. L., Martire, A., Ledent, C. A., Ceruti, S., & Abbracchio, M. P. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.005 · Cited by 122
Fernandes, H. B., Baimbridge, K. G., Church, J., Hayden, M. R., & Raymond, L. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3455-07.2007 · Cited by 120
Simpson, J. R., & Ole Isacson, A. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1071 · Cited by 111
Sarzi, E., Brown, M. D., Lebon, S., Chrétien, D., Münnich, A., Rötig, A., & Procaccio, V. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31565 · Cited by 105
Panov, A. V., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00585-4 · Cited by 104
Brustovetsky, N., LaFrance, R., Purl, K. J., Brustovetsky, T., Keene, C. D., Low, W. C., & Dubinsky, J. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03036.x · Cited by 102
Coenzyme Q10:A Review of Its Promise as a Neuroprotectant
Young, A. J., Johnson, S., Steffens, D. C., & Doraiswamy, P. M. (2007) · CNS Spectrums · doi:10.1017/s1092852900020538 · Cited by 101
Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid)
He, F., Zhang, S., Qian, F., & Zhang, C. (1995) · Neurology · doi:10.1212/wnl.45.12.2178 · Cited by 100
Song, C., Zhang, Y.-T., Parsons, C., & Liu, Y.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304240200 · Cited by 100
Gopalakrishnan, L., & Scarpulla, R. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42320-9 · Cited by 99
Ruan, Q., Lesort, M., MacDonald, M. E., & Johnson, G. V. W. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh082 · Cited by 96
Ascorbate treatment attenuates the Huntington behavioral phenotype in mice
Rebec, G. V., Barton, S. J., Marseilles, A. M., & Collins, K. (2003) · Neuroreport · doi:10.1097/00001756-200307010-00015 · Cited by 92
Gellerich, F. N., Gizatullina, Z. Z., Nguyen, H. P., Trumbeckaitė, S., Vielhaber, S., Seppet, E. K., Zierz, S., Landwehrmeyer, G. B., Rieß, O., von Hörsten, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709555200 · Cited by 91
Zourlidou, A., Gidalevitz, T., Kristiansen, M., Landles, C., Woodman, B., Wells, D. J., Latchman, D. S., de Belleroche, J., Tabrizi, S. J., Morimoto, R. I., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm057 · Cited by 91
Zabel, C., Mao, L., Woodman, B., Rohe, M., Wacker, M. A., Kläre, Y., Koppelstaetter, A., Nebrich, G., Klein, O., Grams, S., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800277-mcp200 · Cited by 88
Is the ubiquitin-proteasome system impaired in Huntington’s disease?
Ortega, Z., Díaz-Hernández, M., & Lucas, J. J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7222-8 · Cited by 86
Calcium-dependent Cleavage of Endogenous Wild-type Huntingtin in Primary Cortical Neurons
Goffredo, D., Rigamonti, D., Tartari, M., Micheli, A. D., Verderio, C., Matteoli, M., Zuccato, C., & Cattaneo, E. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200353200 · Cited by 86
Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice
Stack, E. C., Dedeoglu, A., Smith, K. M., Cormier, K., Kubilus, J. K., Bogdanov, M. B., Matson, W. R., Yang, L., Jenkins, B. G., Luthi‐Carter, R., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4318-07.2007 · Cited by 82
Benchoua, A., Trioulier, Y., Diguet, E., Malgorn, C., Gaillard, M., Dufour, N., Elalouf, J., Krajewski, S., Hantraye, P., Déglon, N., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn033 · Cited by 80
Self-citationThe therapeutic role of creatine in Huntington's disease
Ryu, H., Rosas, H. D., Hersch, S. M., & Ferrante, R. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.008 · Cited by 79
Greene, J. G., Sheu, S. S., Gross, R. A., & Greenamyre, J. T. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00389-8 · Cited by 79
Role of autophagy in the clearance of mutant huntingtin: A step towards therapy?
Ravikumar, B., & Rubinsztein, D. C. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.08.008 · Cited by 78
Ghezzi, D., Viscomi, C. F., Ferlini, A., Gualandi, F., Mereghetti, P., DeGrandis, D., & Zeviani, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn441 · Cited by 77
Ruocco, H. H., Lopes‐Cendes, Í., Li, L. M., Santos‐Silva, M. C., & Cendes, F. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000800016 · Cited by 77
Nasr, P., Gursahani, H., Pang, Z., Bondada, V., Lee, J., Hadley, R. W., & Geddes, J. W. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(02)00229-2 · Cited by 76
The Ubiquitin-Proteasome Pathway in Huntington's Disease
Mitra, S. S., & Finkbeiner, S. M. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.60 · Cited by 76
Jacquard, C., Trioulier, Y., Cosker, F., Escartin, C., Bizat, N., Hantraye, P., Cancela, J., Bonvento, G., & Brouillet, E. (2006) · The FASEB Journal · doi:10.1096/fj.05-5085fje · Cited by 72
Self-citationLee, J.-M., Ivanova, E. V., Seong, I. S., Cashorali, T., Kohane, I., Gusella, J. F., & MacDonald, M. E. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030135 · Cited by 71
Greene, J. G., & Greenamyre, J. T. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052332.x · Cited by 71
Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin
Cyr, M., Sotnikova, T. D., Gainetdinov, R. R., & Caron, M. G. (2006) · The FASEB Journal · doi:10.1096/fj.06-6533fje · Cited by 69
Huntington's disease, energy, and excitotoxicity
Beal, M. F. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90132-5 · Cited by 67
Klivènyi, P., Ferrante, R. J., Gardian, G., Browne, S. E., Chabrier, P., & Beal, M. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.t01-1-01868.x · Cited by 66
A MELAS-Associated ND1 Mutation Causing Leber Hereditary Optic Neuropathy and Spastic Dystonia
Spruijt, L., Smeets, H. J. M., Hendrickx, A. T. M., Bettink‐Remeijer, M. W., Maat‐Kievit, A., Schoonderwoerd, K. C., Sluiter, W. J., de Coo, I. F. M., & Hintzen, R. Q. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.890 · Cited by 62
Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo
Charvin, D., Roze, E. F., Perrin, V., Deyts, C., Bétuing, S., Pagès, C., Régulier, E., Luthi‐Carter, R., Brouillet, E., Déglon, N., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.028 · Cited by 61
Self-citationLee, S., & Kim, M. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.022 · Cited by 47
Inositol 1,4,5-tripshosphate receptor, calcium signalling and huntington’s disease
Борисович, Б. И. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_11 · Cited by 45
Protective roles for induction of autophagy in multiple proteinopathies
Menzies, F. M., Ravikumar, B., & Rubinsztein, D. C. (2006) · Autophagy · doi:10.4161/auto.2696 · Cited by 45
3-nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons
Weller, M., & Paul, S. M. (1993) · European Journal of Pharmacology Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(93)90048-u · Cited by 42
Huntington's disease: progress and potential in the field
Stack, E. C., & Ferrante, R. J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.12.1933 · Cited by 41
Does tissue transglutaminase play a role in Huntington's disease?
Lesort, M. J., Chun, W., Tucholski, J., & Johnson, G. V. W. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00059-6 · Cited by 39
Majumder, P., Raychaudhuri, S., Chattopadhyay, B., & Bhattacharyya, N. P. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9220-7 · Cited by 35
Martin, J., de Vyver, F. L. V., Scholte, H. R., Roodhooft, A. M., Ceuterick, C., Martin, L., & Luyt‐Houwen, I. E. M. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90124-4 · Cited by 31
Schuh, R. A., Kristián, T., & Fiskum, G. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02873.x · Cited by 26
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Cited by
Synaptic Energy Use and Supply
Harris, J. J., Jolivet, R., & Attwell, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.019 · Cited by 1,747
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 827
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
Reddy, P. H., & Oliver, D. M. (2019) · Cells · doi:10.3390/cells8050488 · Cited by 496
“, Huntington’s disease [39], amyotrophic lateral sclerosis [40], Parkinson’s disease [41], Friedreich ataxia [42], Alzheimer’s disease [43]), and chronic liver diseases (e.”
BackgroundMitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Metadata
- Authors
- Damiano, M., Galvan, L., Déglon, N., & Brouillet, E.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 1802
- Issue
- 1
- Pages
- 52-61
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2106902774
- Cited by
- 284
- References
- 162
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.